glutamic acid has been researched along with Anankastic Personality in 87 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.15) | 18.7374 |
1990's | 2 (2.30) | 18.2507 |
2000's | 23 (26.44) | 29.6817 |
2010's | 47 (54.02) | 24.3611 |
2020's | 14 (16.09) | 2.80 |
Authors | Studies |
---|---|
Baerentzen, SL; Casado-Sainz, A; Cumming, P; Fisher, PM; Gudmundsen, F; Keller, SH; Kjaerby, C; Lange, D; Lee, H; Martinez-Tejada, I; Medina, S; Palner, M; Ringsted, A; Schain, M; Svarer, C | 1 |
de Joode, NT; Hagen, K; Hansen, B; Kvale, G; Ousdal, OT; Pouwels, PJW; Thorsen, AL; van den Heuvel, OA; Vester, EL; Vriend, C | 1 |
Berger, B; Domschke, K; Endres, D; Hannibal, L; Nickel, K; Prüss, H; Runge, K; Schiele, MA; Tebartz van Elst, L; Venhoff, N; Zaltenbach, B | 1 |
Guo, G; Hua, G; Quan, D; Wang, J; Wang, S; Yao, S; Zheng, H | 1 |
Gao, J; Guo, G; Luo, G; Quan, D; Wang, S; Yao, S; Zheng, H | 1 |
Chamberlain, SR; Jalal, B; Sahakian, BJ | 1 |
Banca, P; Biria, M; de Souza, AMFLP; Ersche, KD; Healy, MP; Keser, E; Marzuki, AA; Robbins, TW; Rodgers, CT; Rua, C; Sawiak, SJ; Sule, A | 1 |
Brunovský, M; Fajnerová, I; Greguš, D; Horáček, J; Kosová, E; Pajuelo, D; Stopková, P | 1 |
Alonso, P; Cano, M; Cardoner, N; Fullana, MA; Giménez, M; Kegeles, LS; Martínez-Zalacaín, I; Menchón, JM; Munuera, J; Real, E; Segalàs, C; Soriano-Mas, C; Weinstein, JJ; Xu, X | 1 |
Guo, G; Hua, G; Jia, F; Quan, D; Wang, S; Wang, W; Yang, W; Zhang, B; Zheng, H | 1 |
Guo, G; Hua, G; Li, G; Quan, D; Yao, S; Zheng, H | 1 |
Alger, JR; Levitt, JG; McCracken, JT; O'Neill, J; Peris, TS; Piacentini, J; Posse, S; Salgari, G; Vreeland, A | 1 |
Banca, P; Biria, M; Cantonas, LM | 1 |
Banaschewski, T; Brandeis, D; Buitelaar, JK; Durston, S; Gooskens, B; Hohmann, S; Hollestein, V; Kaiser, A; Lythgoe, DJ; Naaijen, J; Oranje, B; Williams, SCR | 1 |
Alger, JR; Armstrong, CC; Bergman, L; Chang, S; Hellemann, GS; Lai, TM; Levitt, JG; Ly, R; McCracken, JT; Mudgway, R; Nurmi, EL; O'Neill, J; Peris, T; Piacentini, J; Posse, S; Rozenman, M; Salamon, N; Vreeland, A | 1 |
Bult-Ito, A; Greene, DM; Juckel, G; Mavrogiorgou, P; Schaper, H; Sohr, R; Winter, C | 1 |
Banaschewski, T; Dijkhuizen, RM; Dittmann, RW; Durston, S; Glennon, JC; Häge, A; K Buitelaar, J; Mechler, K; Murphy, D; Schweinfurth, N; Tactics Consortium, T; Williams, S | 1 |
Arriagada, G; Cisternas-Olmedo, M; Delgado-Acevedo, C; González, LF; Henríquez-Belmar, F; Moya, PR; Murphy, DL; Sotomayor-Zárate, R | 1 |
Brunovský, M; Horáček, J; Polák, J; Vlček, P | 1 |
Ajilore, O; Deshpande, R; Feusner, JD; Ly, R; Moody, T; Morfini, F; O'Neill, J; Tadayonnejad, R | 1 |
Albert, U; Marazziti, D; Mucci, F; Piccinni, A | 1 |
Brandeis, D; Buitelaar, JK; Durston, S; Forde, NJ; Franke, B; Glennon, JC; Lythgoe, DJ; Naaijen, J; Williams, SC; Zwiers, MP | 1 |
Jeong, GW; Moon, CM | 1 |
Fernandez, TV; Leckman, JF; Pittenger, C | 1 |
Cao, X; Chen, Y; Fan, Q; Gao, R; Li, Y; Meng, Z; Tan, L; Wang, Z; Zhang, H; Zhang, Z; Zhu, Y | 1 |
Ivanova, SA; Loonen, AJM | 1 |
Chen, S; Ji, G; Li, J; Luo, MH; Luo, Y; Mao, Y; Song, Z; Sun, T; Tao, W; Tian, W; Tian, Y; Wang, H; Wang, K; Wang, L; Xie, W; Zhang, Z; Zhao, F; Zhong, H; Zhou, J; Zhu, C | 1 |
Konen, C; Niederst, E | 1 |
Agarwal, K; Jagannathan, NR; Khandelwal, SK; Parmar, A; Sharan, P; Sharma, U | 1 |
Chen, W; Edden, RAE; He, N; Jin, H; Li, Y; Voon, V; Yan, F; Zhang, CC; Zhang, Y | 1 |
Askland, K; Gesmonde, J; Greenberg, BD; Kao, HT; Porton, B; Rasmussen, SA; Rudnick, G; Serra, LM | 1 |
Fortune, D; Grados, MA; Specht, MW; Sung, HM | 1 |
Tanaka, K | 1 |
Abramovitch, A; Geller, DA; Pauls, DL; Rauch, SL | 1 |
Grados, M; Kim, S; Srivastava, S; Sung, HM | 1 |
Percinel, I; Yazici, KU | 2 |
Bargalló, N; Falcon, C; Lázaro, L; Morer, A; Ortiz, AE; Ortiz, AG; Plana, MT | 1 |
Athey, AJ; Baker, JT; Brennan, BP; Hudson, JI; Jenike, MA; Jensen, JE; Juelich, RJ; Killgore, WD; Pope, HG; Rauch, SL; Ryan, EM; Schwab, ZJ; Tkachenko, O | 1 |
Amiri, H; Buitelaar, JK; Glennon, JC; Lythgoe, DJ; Naaijen, J | 1 |
Hunter, L; Kegeles, LS; Kimeldorf, MB; Mao, X; Pearlstein, SL; Shungu, DC; Simpson, HB; Slifstein, M; Van Meter, P; Xu, X | 1 |
Chen, J; Fan, Q; Han, X; Li, Y; Maletic-Savatic, M; Tan, L; Tong, S; Wang, Z; Xiao, Z; Zhang, H; Zhang, Z; Zhu, Y | 1 |
Flood, P; Hunter, L; Kegeles, LS; Levinson, A; Mao, X; Milak, MS; Moore, H; Ogden, RT; Rodriguez, CI; Shungu, DC; Simpson, HB; Vermes, D; Xie, S | 1 |
Bargalló, N; Calvo, A; Gassó, P; Lafuente, A; Lázaro, L; Mas, S; Morer, A; Ortiz, AE | 1 |
Grados, M; Halls, A; Prazak, M; Saif, A | 1 |
Banaschewski, T; Buitelaar, JK; Dijkhuizen, RM; Dittmann, RW; Franke, B; Häge, A; Lythgoe, DJ; Mechler, K; Williams, SC | 1 |
Chamberlain, SR; Grant, JE; Kim, SW; Leppink, EW; Odlaug, BL; Redden, SA | 1 |
Choi, NG; Jeong, GW; Park, SE | 1 |
Amiri, H; Banaschewski, T; Boecker-Schlier, R; Brandeis, D; Buitelaar, JK; Durston, S; Franke, B; Glennon, JC; Lythgoe, DJ; Naaijen, J; Oranje, B; Ruf, M; Williams, SCR; Wolf, I; Zwiers, MP | 1 |
Cath, DC; Fan, S; Pouwels, PJW; Schöls, C; van den Heuvel, OA; van der Werf, YD; Veltman, DJ | 1 |
Fontenelle, LF; Mendlowicz, MV | 1 |
Carlsson, A; Carlsson, ML; Ekholm, S; Forssell-Aronsson, E; Ivarsson, T; Jönsson, L; Ljungberg, M; Lundberg, S; Nilsson, M; Ribbelin, S; Starck, G | 1 |
Deco, G; Loh, M; Rolls, ET | 1 |
Nissen, JB; Thomsen, PH | 1 |
MacMaster, FP; O'Neill, J; Rosenberg, DR | 1 |
van der Wee, NJ; Vinkers, DJ | 1 |
Arnold, PD; Burroughs, E; Easter, PC; Hanna, GL; Kennedy, JL; Macmaster, FP; Mirza, Y; Richter, MA; Rose, M; Rosenberg, DR; Sicard, T | 1 |
Bhattacharyya, S; Chakrabarty, K; Christopher, R; Khanna, S; Mahadevan, A; Shankar, SK | 1 |
Aouizerate, B; Bioulac, B; Burbaud, P; Guehl, D; Rotge, JY; Tignol, J | 1 |
MacMaster, FP | 1 |
Baroni, S; Catena Dell'Osso, M; Consoli, G; Marazziti, D | 1 |
Berlin, HA; Chaplin, W; Hollander, E; Jenike, MA; Koran, LM; Pallanti, S; Shapira, NA | 1 |
Ghalib, K; Heleniak, C; Puliafico, A; Rikhi, P; Rynn, M; Vidair, H | 1 |
Bloch, MH; Pittenger, C; Williams, K | 1 |
Anderson, LR; Arnold, PD; Hanna, GL; Himle, JA; Jones, ST; Kennedy, JL; Richter, MA; Ruggiero, AM; Veenstra-VanderWeele, J; Xu, T | 1 |
Bender, J; Kegeles, LS; Mao, X; Shungu, DC; Simpson, HB; Slifstein, M; Xu, X | 1 |
Arnold, PD; Easter, P; Hanna, GL; Kennedy, JL; Rosenberg, DR; Wu, K | 1 |
Chang, S; Feusner, JD; Gorbis, E; Levitt, JG; Maidment, KM; O'Neill, J; Ringman, JM; Salamon, N; Saxena, S; Yip, JC | 1 |
Castro-Fornieles, J; Gassó, P; Lafuente, A; Lazaro, L; Martinez, E; Mas, S; Milà, M; Moreno, E; Plana, MT | 1 |
SCHWOBEL, G | 1 |
Arnold, PD; Richter, MA; Zai, G | 1 |
Banerjee, SP; Bhandari, R; Boyd, C; Ivey, J; Mirza, Y; Moore, GJ; Rose, M; Rosenberg, DR; Russell, A; Smith, JM; Tang, J | 1 |
Bhattacharyya, S; Chakrabarty, K; Christopher, R; Khanna, S | 1 |
Bennett, M; Mancini, C; Patterson, B; Van Ameringen, M | 1 |
Coric, V; Krystal, JH; Pittenger, C | 1 |
Blier, P; Flament, MF; Habib, R | 1 |
Bhattacharyya, S; Chakraborty, K | 1 |
Egashira, N; Fujiwara, M; Harada, S; Iwasaki, K; Matsushita, M; Mishima, K; Nishimura, R; Oishi, R; Okuno, R | 1 |
Fornito, A; Harrison, BJ; Pantelis, C; Pujol, J; Velakoulis, D; Wellard, RM; Wood, SJ; Yücel, M | 1 |
MacMaster, FP; Moore, GJ; Rosenberg, DR; Stewart, C | 1 |
Burton, FH; Campbell, KM; McGrath, MJ | 1 |
Fitzgerald, KD; Keshavan, MS; MacMaster, FP; Moore, GJ; Rosenberg, DR; Stewart, CM | 1 |
Carlsson, ML | 2 |
MacMillan, SN; Moore, GJ; Rosenberg, DR | 1 |
Bolton, J; MacMillan, S; Moore, GJ; Rosenberg, DR; Stewart, CM | 1 |
24 review(s) available for glutamic acid and Anankastic Personality
Article | Year |
---|---|
Obsessive-compulsive disorder: Etiology, neuropathology, and cognitive dysfunction.
Topics: Cognitive Dysfunction; Glutamic Acid; Humans; Mental Processes; Obsessive-Compulsive Disorder | 2023 |
Neurochemical correlates of behavioral treatment of pediatric trichotillomania.
Topics: Adolescent; Behavior Therapy; Child; Female; Glutamic Acid; Gyrus Cinguli; Humans; Obsessive-Compulsive Disorder; Trichotillomania | 2020 |
Glutamatergic Agents in the Treatment of Compulsivity and Impulsivity in Child and Adolescent Psychiatry: a Systematic Review of the Literature.
Topics: Acetylcysteine; Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Brain; Child; Corpus Striatum; Excitatory Amino Acid Agents; Glutamic Acid; Humans; Memantine; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Receptors, Glutamate; Risk Assessment; Treatment Outcome | 2018 |
The Glutamate and the Immune Systems: New Targets for the Pharmacological Treatment of OCD.
Topics: Drug Resistance; Excitatory Amino Acid Agents; Glutamic Acid; Humans; Immune System; Neurotransmitter Agents; Obsessive-Compulsive Disorder | 2018 |
Genetic susceptibility in obsessive-compulsive disorder.
Topics: Animals; Disease Models, Animal; DNA Copy Number Variations; Genetic Predisposition to Disease; Glutamic Acid; Humans; Mice; Obsessive-Compulsive Disorder; Signal Transduction | 2018 |
Glutamate drugs and pharmacogenetics of OCD: a pathway-based exploratory approach.
Topics: Animals; Central Nervous System; Glutamic Acid; Humans; Obsessive-Compulsive Disorder | 2013 |
[Role of glutamate transporters in the pathophysiology of major mental illnesses].
Topics: Amino Acid Transport System X-AG; Animals; Autistic Disorder; Depressive Disorder; Disease Models, Animal; Drug Discovery; Excitatory Amino Acid Transporter 1; Excitatory Amino Acid Transporter 2; Glutamic Acid; Humans; Mice; Molecular Targeted Therapy; Mutation; Obsessive-Compulsive Disorder; Schizophrenia | 2013 |
Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective.
Topics: Brain; Dopamine; Environment; Family Health; Glutamic Acid; Humans; Neurobiology; Obsessive-Compulsive Disorder; Risk Factors; Signal Transduction | 2014 |
Genetic findings in obsessive-compulsive disorder connect to brain-derived neutrophic factor and mammalian target of rapamycin pathways: implications for drug development.
Topics: Animals; Brain-Derived Neurotrophic Factor; Central Nervous System; Drug Discovery; Gene Regulatory Networks; Glutamic Acid; Humans; Neuroprotective Agents; Obsessive-Compulsive Disorder; Signal Transduction; TOR Serine-Threonine Kinases | 2014 |
Fronto-striatal glutamatergic compounds in compulsive and impulsive syndromes: a review of magnetic resonance spectroscopy studies.
Topics: Corpus Striatum; Frontal Lobe; Glutamic Acid; Humans; Magnetic Resonance Spectroscopy; Neural Pathways; Obsessive-Compulsive Disorder | 2015 |
A review of animal models of obsessive-compulsive disorder: a focus on developmental, immune, endocrine and behavioral models.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Drug Discovery; Glutamic Acid; Humans; Neuroprotective Agents; Obsessive-Compulsive Disorder; Phenotype; Serotonin Agents | 2016 |
Brain imaging in pediatric obsessive-compulsive disorder.
Topics: Adolescent; Adult; Basal Ganglia; Brain; Child; Corpus Callosum; Corpus Striatum; Frontal Lobe; Glutamic Acid; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Nerve Net; Obsessive-Compulsive Disorder; Organ Size; Thalamus | 2008 |
The glutamate-based genetic immune hypothesis in obsessive-compulsive disorder. An integrative approach from genes to symptoms.
Topics: Animals; Brain; Excitatory Amino Acid Transporter 3; Glutamic Acid; Humans; Models, Neurological; Obsessive-Compulsive Disorder | 2010 |
[Physiopathology of obsessive-compulsive disorder--special reference to aspects of the neurochemistry].
Topics: Brain; Diagnostic Imaging; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Neurochemistry; Obsessive-Compulsive Disorder; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins | 2009 |
Translational neuroimaging research in pediatric obsessive-compulsive disorder.
Topics: Amino Acid Transport System X-AG; Animals; Diagnostic Imaging; Disease Models, Animal; Glutamic Acid; Humans; Magnetic Resonance Spectroscopy; Models, Biological; Obsessive-Compulsive Disorder; Pediatrics; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors; Translational Research, Biomedical | 2010 |
Past, present and future drugs for the treatment of obsessive-compulsive disorder.
Topics: Antidepressive Agents; Clomipramine; Glutamic Acid; Humans; Obsessive-Compulsive Disorder; Receptors, N-Methyl-D-Aspartate; Second Messenger Systems; Selective Serotonin Reuptake Inhibitors | 2010 |
Advances in pharmacotherapy for pediatric anxiety disorders.
Topics: Adolescent; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Behavior Therapy; Brain; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Evidence-Based Medicine; Female; Glutamic Acid; Humans; Male; Obsessive-Compulsive Disorder; Phobic Disorders; Randomized Controlled Trials as Topic; Risk Assessment; Selective Serotonin Reuptake Inhibitors | 2011 |
Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment.
Topics: Animals; Clinical Trials as Topic; Drug Evaluation, Preclinical; Glutamic Acid; Humans; Neurobiology; Neurotransmitter Agents; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic | 2011 |
Genetics of anxiety disorders.
Topics: Anxiety Disorders; Brain-Derived Neurotrophic Factor; Catechol O-Methyltransferase; Child; Cholecystokinin; Gene Expression; Genetic Linkage; Glutamic Acid; Humans; Inhibition, Psychological; Membrane Glycoproteins; Membrane Transport Proteins; Molecular Biology; Nerve Tissue Proteins; Neurotic Disorders; Obsessive-Compulsive Disorder; Panic Disorder; Phenotype; Point Mutation; Serotonin; Serotonin Plasma Membrane Transport Proteins | 2004 |
Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder.
Topics: Antidepressive Agents, Tricyclic; Brain; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Magnetic Resonance Imaging; Obsessive-Compulsive Disorder | 2006 |
Pharmacotherapies in the management of obsessive-compulsive disorder.
Topics: Adolescent; Antipsychotic Agents; Brain; Child; Clinical Trials as Topic; Glutamic Acid; Humans; Nerve Net; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors | 2006 |
Glutamatergic dysfunction--newer targets for anti-obsessional drugs.
Topics: Animals; Disease Models, Animal; Glutamic Acid; Humans; Magnetic Resonance Imaging; Neurotransmitter Agents; Obsessive-Compulsive Disorder; Patents as Topic; Receptors, Glutamate | 2007 |
On the role of cortical glutamate in obsessive-compulsive disorder and attention-deficit hyperactivity disorder, two phenomenologically antithetical conditions.
Topics: Acetylcholine; Adolescent; Adult; Aged; Attention Deficit Disorder with Hyperactivity; Cerebral Cortex; Child; Child, Preschool; Dopamine; Female; Glutamic Acid; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Serotonin | 2000 |
On the role of prefrontal cortex glutamate for the antithetical phenomenology of obsessive compulsive disorder and attention deficit hyperactivity disorder.
Topics: Acetylcholine; Attention Deficit Disorder with Hyperactivity; Child; Dopamine; Glutamic Acid; Humans; Models, Neurological; Obsessive-Compulsive Disorder; Prefrontal Cortex; Serotonin | 2001 |
6 trial(s) available for glutamic acid and Anankastic Personality
Article | Year |
---|---|
Direct changes of neurometabolic concentrations in the pregenual anterior cingulate cortex among obsessive-compulsive patients after repetitive transcranial magnetic stimulation treatment.
Topics: Adult; Anxiety; Female; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Obsessive-Compulsive Disorder; Time Factors; Transcranial Magnetic Stimulation; Young Adult | 2023 |
Glutamate in Pediatric Obsessive-Compulsive Disorder and Response to Cognitive-Behavioral Therapy: Randomized Clinical Trial.
Topics: Adolescent; Child; Cognitive Behavioral Therapy; Cross-Over Studies; Female; Glutamic Acid; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Obsessive-Compulsive Disorder; Treatment Outcome; Waiting Lists | 2017 |
In vivo effects of ketamine on glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder: Proof of concept.
Topics: Adult; Cross-Over Studies; Excitatory Amino Acid Antagonists; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Ketamine; Male; Obsessive-Compulsive Disorder; Prefrontal Cortex; Proton Magnetic Resonance Spectroscopy; Treatment Outcome | 2015 |
Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) - study protocol for a randomised controlled trial.
Topics: Adolescent; Adolescent Behavior; Autism Spectrum Disorder; Brain; Child; Child Behavior; Clinical Protocols; Double-Blind Method; Europe; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Humans; Male; Memantine; Neuroimaging; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Research Design; Time Factors; Treatment Outcome | 2016 |
N-Acetylcysteine in the Treatment of Excoriation Disorder: A Randomized Clinical Trial.
Topics: Acetylcysteine; Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Glutamic Acid; Humans; Male; Middle Aged; Nucleus Accumbens; Obsessive-Compulsive Disorder; Self-Injurious Behavior; Skin; Young Adult | 2016 |
Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder.
Topics: Adolescent; Adult; Aged; Double-Blind Method; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Female; Fructose; Glutamic Acid; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Topiramate; Treatment Outcome; Young Adult | 2011 |
57 other study(ies) available for glutamic acid and Anankastic Personality
Article | Year |
---|---|
Dorsal striatal dopamine induces fronto-cortical hypoactivity and attenuates anxiety and compulsive behaviors in rats.
Topics: Animals; Anxiety; Compulsive Behavior; Corpus Striatum; Dopamine; Female; Glutamic Acid; Obsessive-Compulsive Disorder; Rats | 2022 |
Longitudinal changes in neurometabolite concentrations in the dorsal anterior cingulate cortex after concentrated exposure therapy for obsessive-compulsive disorder.
Topics: Child; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Implosive Therapy; Magnetic Resonance Imaging; Obsessive-Compulsive Disorder | 2022 |
Case Report: Possible autoimmune obsessive-compulsive disorder with postpartum onset.
Topics: Animals; Autoantibodies; Dopamine; Female; Glutamic Acid; Humans; Mice; Obsessive-Compulsive Disorder; Postpartum Period | 2022 |
Glutamatergic neurotransmission is affected by low-frequency repetitive transcranial magnetic stimulation over the supplemental motor cortex of patients with obsessive-compulsive disorder.
Topics: Glutamic Acid; Glutamine; Humans; Motor Cortex; Obsessive-Compulsive Disorder; Transcranial Magnetic Stimulation; Treatment Outcome | 2023 |
Cortical glutamate and GABA are related to compulsive behaviour in individuals with obsessive compulsive disorder and healthy controls.
Topics: Compulsive Behavior; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Magnetic Resonance Imaging; Obsessive-Compulsive Disorder; Proton Magnetic Resonance Spectroscopy | 2023 |
Glutamatergic abnormalities in the pregenual anterior cingulate cortex in obsessive-compulsive disorder using magnetic resonance spectroscopy: A controlled study.
Topics: gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Obsessive-Compulsive Disorder | 2023 |
Is glutamate associated with fear extinction and cognitive behavior therapy outcome in OCD? A pilot study.
Topics: Adult; Cognitive Behavioral Therapy; Extinction, Psychological; Fear; Female; Galvanic Skin Response; Glutamic Acid; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Obsessive-Compulsive Disorder; Outcome Assessment, Health Care; Pilot Projects; Prefrontal Cortex; Severity of Illness Index; Young Adult | 2020 |
Reduced anterior cingulate glutamate of comorbid skin-picking disorder in adults with obsessive-compulsive disorder.
Topics: Adult; Cross-Sectional Studies; Female; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Obsessive-Compulsive Disorder | 2020 |
Analysis of magnetic resonance spectroscopy in patients with obsessive
Topics: Adult; Female; Glutamic Acid; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Obsessive-Compulsive Disorder | 2020 |
Magnetic Resonance Spectroscopy (MRS) and Positron Emission Tomography (PET) Imaging in Obsessive-Compulsive Disorder.
Topics: Aspartic Acid; Creatine; Glutamic Acid; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Obsessive-Compulsive Disorder; Positron-Emission Tomography | 2021 |
Developmental changes in fronto-striatal glutamate and their association with functioning during inhibitory control in autism spectrum disorder and obsessive compulsive disorder.
Topics: Adolescent; Autism Spectrum Disorder; Corpus Striatum; Glutamic Acid; Humans; Magnetic Resonance Imaging; Obsessive-Compulsive Disorder | 2021 |
Altered serotonergic and GABAergic neurotransmission in a mice model of obsessive-compulsive disorder.
Topics: Analysis of Variance; Animals; Animals, Newborn; Brain; Disease Models, Animal; Dopamine; gamma-Aminobutyric Acid; Glutamic Acid; Mice; Mice, Inbred Strains; Neural Pathways; Obsessive-Compulsive Disorder; Serotonin; Synaptic Transmission | 2018 |
Neurochemical and behavioral characterization of neuronal glutamate transporter EAAT3 heterozygous mice.
Topics: Animals; Disease Models, Animal; Excitatory Amino Acid Transporter 3; Genotype; Glutamic Acid; Heterozygote; Male; Mice; Obsessive-Compulsive Disorder | 2017 |
Role of Glutamatergic System in Obsessive-Compulsive Disorder with Possible Therapeutic Implications.
Topics: Brain; Cognition Disorders; Excitatory Amino Acid Agents; Female; Glutamic Acid; Humans; Male; Neuropsychological Tests; Obsessive-Compulsive Disorder; Receptors, Glutamate | 2018 |
Pregenual Anterior Cingulate Dysfunction Associated with Depression in OCD: An Integrated Multimodal fMRI/
Topics: Adult; Case-Control Studies; Depression; Female; Functional Neuroimaging; Glutamic Acid; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Neural Pathways; Obsessive-Compulsive Disorder; Proton Magnetic Resonance Spectroscopy; Young Adult | 2018 |
Striatal structure and its association with N-Acetylaspartate and glutamate in autism spectrum disorder and obsessive compulsive disorder.
Topics: Adolescent; Aspartic Acid; Autism Spectrum Disorder; Child; Corpus Striatum; Female; Functional Laterality; Glutamic Acid; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Obsessive-Compulsive Disorder; Organ Size; Proton Magnetic Resonance Spectroscopy | 2018 |
Associations of neurofunctional, morphometric and metabolic abnormalities with clinical symptom severity and recognition deficit in obsessive-compulsive disorder.
Topics: Adult; Aspartic Acid; Brain; Brain Mapping; Case-Control Studies; Choline; Creatine; Female; Glutamic Acid; Humans; Magnetic Resonance Imaging; Male; Memory, Short-Term; Obsessive-Compulsive Disorder; Proton Magnetic Resonance Spectroscopy | 2018 |
The right thalamic glutamate level correlates with functional connectivity with right dorsal anterior cingulate cortex/middle occipital gyrus in unmedicated obsessive-compulsive disorder: A combined fMRI and
Topics: Adult; Case-Control Studies; Female; Functional Laterality; Functional Neuroimaging; Glutamic Acid; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Neural Pathways; Obsessive-Compulsive Disorder; Occipital Lobe; Prefrontal Cortex; Proton Magnetic Resonance Spectroscopy; Thalamus; Young Adult | 2019 |
Consider Role of Glutamatergic Habenula-projecting Globus Pallidus in OCD.
Topics: Animals; Globus Pallidus; Glutamic Acid; Habenula; Obsessive-Compulsive Disorder | 2019 |
Basolateral amygdala input to the medial prefrontal cortex controls obsessive-compulsive disorder-like checking behavior.
Topics: Amygdala; Animals; Basolateral Nuclear Complex; Disease Models, Animal; Glutamic Acid; Humans; Magnetic Resonance Imaging; Mice; Neural Pathways; Neurons; Obsessive-Compulsive Disorder; Prefrontal Cortex | 2019 |
Special Issue on Disease: New Advances in Psychiatry.
Topics: Animals; Brain; Cerebellum; Depression, Postpartum; Depressive Disorder; Female; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Mental Disorders; Neural Pathways; Neuropsychiatry; Obsessive-Compulsive Disorder; Pregnancy; Pregnancy Complications; Primates; Psychiatry; Stress Disorders, Post-Traumatic; Substance-Related Disorders | 2019 |
Brain neurochemistry in unmedicated obsessive-compulsive disorder patients and effects of 12-week escitalopram treatment:
Topics: Adolescent; Adult; Case-Control Studies; Caudate Nucleus; Choline; Citalopram; Female; Follow-Up Studies; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Inositol; Male; Middle Aged; Obsessive-Compulsive Disorder; Proton Magnetic Resonance Spectroscopy; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Thalamus; Young Adult | 2019 |
Investigation of anterior cingulate cortex gamma-aminobutyric acid and glutamate-glutamine levels in obsessive-compulsive disorder using magnetic resonance spectroscopy.
Topics: Adult; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Obsessive-Compulsive Disorder; Young Adult | 2019 |
Isoforms of the neuronal glutamate transporter gene, SLC1A1/EAAC1, negatively modulate glutamate uptake: relevance to obsessive-compulsive disorder.
Topics: Adolescent; Adult; Aged; Animals; Excitatory Amino Acid Transporter 3; Female; Glutamic Acid; HEK293 Cells; HeLa Cells; Humans; Male; Mice; Mice, Inbred C57BL; Middle Aged; Obsessive-Compulsive Disorder; Promoter Regions, Genetic; Protein Isoforms; Young Adult | 2013 |
Glutamatergic dysfunction in skin-picking disorder: treatment of a pediatric patient with N-acetylcysteine.
Topics: Acetylcysteine; Child; Female; Glutamic Acid; Humans; Obsessive-Compulsive Disorder; Self-Injurious Behavior; Skin; Treatment Outcome | 2014 |
The role of glutamatergic dysfunction in treatment-resistant obsessive-compulsive disorder: treatment of an adolescent case with N-acetylcysteine augmentation.
Topics: Acetylcysteine; Adolescent; Female; Glutamic Acid; Humans; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales | 2014 |
1H-MRS of the anterior cingulate cortex in childhood and adolescent obsessive-compulsive disorder: a case-control study.
Topics: Adolescent; Aspartic Acid; Case-Control Studies; Child; Female; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Inositol; Male; Obsessive-Compulsive Disorder; Proton Magnetic Resonance Spectroscopy; Psychiatric Status Rating Scales | 2015 |
An Examination of Rostral Anterior Cingulate Cortex Function and Neurochemistry in Obsessive-Compulsive Disorder.
Topics: Adolescent; Adult; Female; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Obsessive-Compulsive Disorder; Oxygen; Protons; Psychiatric Status Rating Scales; Young Adult | 2015 |
Assessment of glutamate in striatal subregions in obsessive-compulsive disorder with proton magnetic resonance spectroscopy.
Topics: Adolescent; Adult; Corpus Striatum; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Proton Magnetic Resonance Spectroscopy; Young Adult | 2015 |
Decreased thalamic glutamate level in unmedicated adult obsessive-compulsive disorder patients detected by proton magnetic resonance spectroscopy.
Topics: Adult; Case-Control Studies; Confounding Factors, Epidemiologic; Creatine; Female; Glutamic Acid; Humans; Male; Middle Aged; Multivariate Analysis; Obsessive-Compulsive Disorder; Phosphocreatine; Proton Magnetic Resonance Spectroscopy; Sample Size; Severity of Illness Index; Signal Transduction; Thalamus | 2015 |
Association between genetic variants related to glutamatergic, dopaminergic and neurodevelopment pathways and white matter microstructure in child and adolescent patients with obsessive-compulsive disorder.
Topics: Adolescent; Anisotropy; Cadherins; Child; Diffusion Tensor Imaging; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Excitatory Amino Acid Transporter 3; Excitatory Amino Acids; Female; Genetic Variation; Glutamic Acid; Humans; Male; Nerve Tissue Proteins; Neural Pathways; Neuroimaging; Obsessive-Compulsive Disorder; Polymorphism, Single Nucleotide; Receptors, Dopamine D3; Receptors, Nerve Growth Factor; White Matter | 2015 |
Metabolic abnormality in the right dorsolateral prefrontal cortex in patients with obsessive-compulsive disorder: proton magnetic resonance spectroscopy.
Topics: Adult; Aspartic Acid; Brain; Choline; Female; Glutamic Acid; Glutamine; Humans; Inositol; Lactic Acid; Male; Neuroimaging; Obsessive-Compulsive Disorder; Prefrontal Cortex; Proton Magnetic Resonance Spectroscopy; Young Adult | 2017 |
Fronto-Striatal Glutamate in Autism Spectrum Disorder and Obsessive Compulsive Disorder.
Topics: Adolescent; Autism Spectrum Disorder; Child; Corpus Striatum; Female; Frontal Lobe; Glutamic Acid; Humans; Magnetic Resonance Spectroscopy; Male; Obsessive-Compulsive Disorder | 2017 |
Abnormalities in metabolite concentrations in tourette's disorder and obsessive-compulsive disorder-A proton magnetic resonance spectroscopy study.
Topics: Adult; Choline; Female; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Proton Magnetic Resonance Spectroscopy; Thalamus; Tourette Syndrome; Young Adult | 2017 |
The Wernicke-Kleist-Leonhard "short-circuiting": a missing link between attention deficit hyperactivity disorder, Tourette syndrome, and obsessive-compulsive disorder?
Topics: Attention Deficit Disorder with Hyperactivity; Glutamic Acid; Humans; Hyperkinesis; Models, Neurological; Obsessive-Compulsive Disorder; Psychotic Disorders; Tourette Syndrome | 2008 |
A 1H magnetic resonance spectroscopy study in adults with obsessive compulsive disorder: relationship between metabolite concentrations and symptom severity.
Topics: Adult; Aspartic Acid; Brain; Brain Mapping; Case-Control Studies; Choline; Creatine; Female; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multivariate Analysis; Obsessive-Compulsive Disorder; Principal Component Analysis; Protons; Severity of Illness Index; Surveys and Questionnaires | 2008 |
An attractor hypothesis of obsessive-compulsive disorder.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Models, Neurological; N-Methylaspartate; Nerve Net; Neurons; Obsessive-Compulsive Disorder; Receptors, AMPA; Receptors, GABA; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission | 2008 |
[Significance of the glutaminergic system for obsessive-compulsive disorder].
Topics: Brain; Glutamic Acid; Humans; Obsessive-Compulsive Disorder; Pharmacogenetics; Receptors, Glutamate | 2008 |
[Topiramate augmentation in treatment-resistant obsessive-compulsive disorder].
Topics: Anticonvulsants; Drug Resistance; Excitatory Amino Acid Antagonists; Fructose; Glutamic Acid; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Topiramate; Treatment Outcome | 2008 |
Glutamate receptor gene (GRIN2B) associated with reduced anterior cingulate glutamatergic concentration in pediatric obsessive-compulsive disorder.
Topics: Adolescent; Age Factors; Brain; Child; Female; Genetic Variation; Genotype; Glutamic Acid; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Obsessive-Compulsive Disorder; Occipital Lobe; Polymorphism, Genetic; Receptors, N-Methyl-D-Aspartate | 2009 |
Anti-brain autoantibodies and altered excitatory neurotransmitters in obsessive-compulsive disorder.
Topics: Adult; Aged; Autoantibodies; Basal Ganglia; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glycine; Humans; Male; Middle Aged; Multivariate Analysis; Neurotransmitter Agents; Obsessive-Compulsive Disorder; Taurine; Thalamus; Young Adult | 2009 |
Functional studies and rare variant screening of SLC1A1/EAAC1 in males with obsessive-compulsive disorder.
Topics: Adolescent; Adult; Child; Excitatory Amino Acid Transporter 3; Genetic Predisposition to Disease; Genetic Testing; Glutamic Acid; Humans; Kinetics; Male; Middle Aged; Obsessive-Compulsive Disorder; Polymorphism, Single Nucleotide; Sequence Analysis, DNA; Young Adult | 2012 |
Investigation of cortical glutamate-glutamine and γ-aminobutyric acid in obsessive-compulsive disorder by proton magnetic resonance spectroscopy.
Topics: Adolescent; Adult; Age of Onset; Brain Chemistry; Cerebral Cortex; Data Interpretation, Statistical; Diagnostic and Statistical Manual of Mental Disorders; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Obsessive-Compulsive Disorder; Young Adult | 2012 |
Glutamate system genes and brain volume alterations in pediatric obsessive-compulsive disorder: a preliminary study.
Topics: Adolescent; Brain; Child; Female; Genetic Association Studies; Genetic Predisposition to Disease; Glutamic Acid; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Nerve Tissue Proteins; Obsessive-Compulsive Disorder; Polymorphism, Single Nucleotide | 2013 |
Effects of intensive cognitive-behavioral therapy on cingulate neurochemistry in obsessive-compulsive disorder.
Topics: Adult; Analysis of Variance; Aspartic Acid; Brain; Choline; Cognitive Behavioral Therapy; Dipeptides; Follow-Up Studies; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neurochemistry; Obsessive-Compulsive Disorder; Pilot Projects; Severity of Illness Index | 2013 |
Common genetic background in anorexia nervosa and obsessive compulsive disorder: preliminary results from an association study.
Topics: Adolescent; Anorexia Nervosa; Child; Cohort Studies; Female; Genetic Association Studies; Genetic Markers; Genetic Predisposition to Disease; Glutamic Acid; Humans; Male; Obsessive-Compulsive Disorder; Pilot Projects; Polymorphism, Single Nucleotide; Serotonin | 2013 |
[Studies on the effect of glutamic acid on psychic functions].
Topics: Glutamic Acid; Humans; Intellectual Disability; Neurasthenia; Neurotic Disorders; Obsessive-Compulsive Disorder | 1950 |
Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls.
Topics: Adolescent; Aspartic Acid; Child; Choline; Creatine; Depressive Disorder, Major; Female; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Obsessive-Compulsive Disorder; Personality Assessment; Phosphocreatine; Reference Values; Synaptic Transmission | 2004 |
Glutamatergic dysfunction in OCD.
Topics: Adolescent; Adult; Analysis of Variance; Female; Glutamic Acid; Humans; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Sex Factors | 2005 |
Topiramate augmentation in treatment-resistant obsessive-compulsive disorder: a retrospective, open-label case series.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Anxiety Disorders; Caudate Nucleus; Drug Resistance; Drug Synergism; Female; Fructose; Glutamic Acid; Humans; Male; Mental Disorders; Middle Aged; Obsessive-Compulsive Disorder; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Topiramate | 2006 |
Effects of glutamate-related drugs on marble-burying behavior in mice: implications for obsessive-compulsive disorder.
Topics: Acoustic Stimulation; Amantadine; Animals; Behavior, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glutamic Acid; Male; Memantine; Mice; Mice, Inbred ICR; Motor Activity; Obsessive-Compulsive Disorder; Quinoxalines; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Reflex, Startle; Riluzole | 2008 |
Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder.
Topics: Adult; Aspartic Acid; Biomarkers; Choline; Creatine; Female; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Neuropsychological Tests; Obsessive-Compulsive Disorder; Predictive Value of Tests; Severity of Illness Index; Sex Factors | 2008 |
Case study: caudate glutamatergic changes with paroxetine therapy for pediatric obsessive-compulsive disorder.
Topics: Caudate Nucleus; Child; Glutamic Acid; Humans; Magnetic Resonance Spectroscopy; Male; Models, Neurological; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors | 1998 |
Behavioral effects of cocaine on a transgenic mouse model of cortical-limbic compulsion.
Topics: Animals; Cerebral Cortex; Cholera Toxin; Cocaine; Disease Models, Animal; Dopamine Uptake Inhibitors; Female; Gene Expression; Glutamic Acid; Humans; Limbic System; Mice; Mice, Inbred BALB C; Mice, Transgenic; Obsessive-Compulsive Disorder; Receptors, Dopamine D1; Stereotyped Behavior; Transgenes | 1999 |
Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine.
Topics: Adolescent; Case-Control Studies; Caudate Nucleus; Child; Confounding Factors, Epidemiologic; Female; Glutamic Acid; Humans; Magnetic Resonance Spectroscopy; Male; Obsessive-Compulsive Disorder; Occipital Lobe; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Treatment Outcome | 2000 |
Brain anatomy and chemistry may predict treatment response in paediatric obsessive--compulsive disorder.
Topics: Adolescent; Age Factors; Brain; Brain Chemistry; Case-Control Studies; Child; Corpus Striatum; Female; Frontal Lobe; Glutamic Acid; Gyrus Cinguli; Humans; Male; Obsessive-Compulsive Disorder; Predictive Value of Tests; Serotonin; Thalamus | 2001 |
Case study: caudate glutamatergic changes with paroxetine persist after medication discontinuation in pediatric OCD.
Topics: Brain Chemistry; Caudate Nucleus; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glutamic Acid; Humans; Magnetic Resonance Spectroscopy; Obsessive-Compulsive Disorder; Paroxetine; Remission Induction; Selective Serotonin Reuptake Inhibitors | 2001 |